Comparative gene and protein expression in primary cultures of epithelial cells from benign prostatic hyperplasia and prostate cancer

Cancer Letters

Volumn 227, Issue 2, 2005, Pages 213-222

  Rose, Amy ^a   Xu, Yue ^a   Chen, Zuxiong ^a   Fan, Zengbin ^a   Stamey, Thomas A ^a   McNeal, John E ^a   Caldwell, Mitchell ^a   Peehl, Donna M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Benign prostatic hyperplasia; Cytokeratin 16; Prostate; Prostate cancer

Indexed keywords

CYTOKERATIN 6;

ARTICLE; CELL CULTURE; COMPARATIVE STUDY; DNA MICROARRAY; EPITHELIUM CELL; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; IMMUNOBLOTTING; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; CELL PROLIFERATION; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; IMMUNOBLOTTING; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE CULTURE TECHNIQUES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 23844469569     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.01.037     Document Type: Article

References (23)

1. L.A.G. Ries, M.P. Eisner, C.L. Kosary, B.F. Hankey, B.A. Miller, and L. Clegg SEER Cancer Statistics Review, 1975-2000 2003 National Cancer Institute Bethesda, MD [ http://seer.cancer.gov/csr/1975_2000/ ]
2. R.S. Kirby The natural history of benign prostatic hyperplasia: what have we learned in the last decade? Urology 56 2000 3 6
3. C.G. Roehrborn, and J.D. McConnell Etiology, pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia P.C. Walsh A.B. Retik E.D. Vaughan Jr. A.J. Wein Campbell's Urology 2002 1297 1336
4. T.A. Stamey, J.A. Warrington, M.C. Caldwell, Z. Chen, Z. Fan, and M. Mahadevappa Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia J. Urol. 166 2001 2171 2177
5. D.M. Peehl Are primary cultures realistic models of prostate cancer? J. Cell Biochem. 91 2004 185 195
6. D.M. Peehl, and R.G. Sellers Epithelial cell culture: prostate A. Atala R. Lanza Methods of Tissue Engineering 2002 Academic Press San Diego 247 261
7. D.F. Gleason Histologic grading and clinical staging of prostatic carcinoma M. Tannenbaum Urologic Pathology: The Prostate 1977 Lea and Febiger Philadelphia 171 197
8. ® probe arrays M. Schena Microarray Biochip Technology 2000 Easton Publishing Natick 119 148
9. D.M. Peehl, R.G. Sellers, and J.E. McNeal Keratin 19 in the adult human prostate: tissue and cell culture studies Cell Tissue Res. 285 1996 171 176
10. R.P. Donn, and D.W. Ray Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule J. Endocrinol. 182 2004 1 9
11. K. Meyer-Siegler, R.A. Fattor, and P.B. Hudson Expression of macrophage migration inhibitory factor in the human prostate Diagn. Mol. Pathol. 7 1998 44 50
12. K. Meyer-Siegler Increased stability of macrophage migration inhibitory factor (MIF) in DU-145 prostate cancer cells J. Interferon. Cytokine Res. 20 2000 769 778
13. M. Abe, J.B. Manola, W.K. Oh, D.L. Parslow, D.J. George, C.L. Austin, and P.W. Kantoff Plasma levels of heat shock protein 70 in patients with prostate cancer: a potential biomarker for prostate cancer Clin. Prostate Cancer 3 2004 49 53
14. M.H. Wang, M.E. Grossmann, and C.Y. Young Forced expression of heat-shock protein 70 increases the secretion of Hsp70 and provides protection against tumour growth Br. J. Cancer 90 2004 926 931
15. S. Ranganathan, H. Salazar, C.A. Benetatos, and G.R. Hudes Immunohistochemical analysis of beta-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy Prostate 30 1997 263 268
16. S. Ranganathan, C.A. Benetatos, P.J. Colarusso, D.W. Dexter, and G.R. Hudes Altered beta-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells Br. J. Cancer 77 1998 562 566
17. S. Fang, and A.M. Weissman A field guide to ubiquitylation Cell Mol. Life Sci. 61 2004 1546 1561
18. L.J. Marton, and A.E. Pegg Polyamines as targets for therapeutic intervention Annu. Rev. Pharmacol. Toxicol. 35 1995 55 91
19. R.R. Mohan, A. Challa, S. Gupta, D.G. Bostwick, N. Ahmad, and R. Agarwal Overexpression of ornithine decarboxylase in prostate cancer and prostatic fluid in humans Clin. Cancer Res. 5 1999 143 147
20. S. Gupta, N. Ahmad, R.R. Mohan, M.M. Husain, and H. Mukhtar Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase Cancer Res. 59 1999 2115 2120
21. C.K. Jiang, T. Magnaldo, M. Ohtsuki, I.M. Freedberg, F. Bernerd, and M. Blumenberg Epidermal growth factor and transforming growth factor alpha specifically induce the activation- and hyperproliferation-associated keratins 6 and 16 Proc. Natl. Acad. Sci. USA 90 1993 6786 6790
22. Y.N. Wang, and W.C. Chang Induction of disease-associated keratin 16 gene expression by epidermal growth factor is regulated through cooperation of transcription factors Sp1 and c-Jun J. Biol. Chem. 278 2003 45848 45857
23. J.B. Welsh, L.M. Sapinoso, A.I. Su, S.G. Kern, J. Wang-Rodriguez, and C.A. Moskaluk Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer Cancer Res. 61 2001 5974 5978